Plus Therapeutics, Inc. (PSTV)
NASDAQ: PSTV · Real-Time Price · USD
0.7879
-0.0548 (-6.50%)
At close: Apr 25, 2025, 4:00 PM
0.7965
+0.0086 (1.09%)
After-hours: Apr 25, 2025, 6:49 PM EDT
Plus Therapeutics Stock Forecast
PSTV's stock price has decreased by -50.76% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Plus Therapeutics stock have an average target of 11.5, with a low estimate of 5.50 and a high estimate of 20. The average target predicts an increase of 1,359.58% from the current stock price of 0.79.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Plus Therapeutics stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 3 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $19 → $20 | Strong Buy | Maintains | $19 → $20 | +2,438.39% | Apr 21, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $8 → $5.5 | Strong Buy | Maintains | $8 → $5.5 | +598.06% | Mar 28, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $9 | Strong Buy | Maintains | $9 | +1,042.28% | Mar 28, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $9 | Strong Buy | Maintains | $9 | +1,042.28% | Mar 21, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Initiates $9 | Strong Buy | Initiates | $9 | +1,042.28% | Mar 17, 2025 |
Financial Forecast
Revenue This Year
6.60M
from 5.82M
Increased by 13.26%
Revenue Next Year
8.22M
from 6.60M
Increased by 24.59%
EPS This Year
-1.03
from -2.34
EPS Next Year
-0.71
from -1.03
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 12.0M | 12.7M | 57.0M | ||
| Avg | 6.6M | 8.2M | 36.5M | ||
| Low | 2.9M | 3.9M | 24.6M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 105.5% | 92.8% | 594.1% | ||
| Avg | 13.3% | 24.6% | 344.5% | ||
| Low | -49.5% | -40.6% | 199.5% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -0.36 | -0.41 | -0.12 | ||
| Avg | -1.03 | -0.71 | -0.26 | ||
| Low | -1.62 | -1.14 | -0.48 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.